Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07445542) titled 'Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia' on Feb. 25.
Study Type: Observational
Primary Sponsor: JW Pharmaceutical
Condition:
Hypercholesterolemia
Recruitment Status: Not recruiting
Date of First Enrollment: December 18, 2021
Target Sample Size: 6927
Countries of Recruitment:
South Korea
To know more, visit https://clinicaltrials.gov/study/NCT07445542
Published by HT Digital Content Services with permission from Health Daily Digest....